PubMed
Nucleotide
Protein
Genome
Structure
PopSet
Taxonomy
OMIM
OMIM Update List for February, 2004
Please send your questions to the
NCBI Help Desk
.
February 27, 2004
New Entries:
608484
CONGENITAL CORNEAL OPACITIES, CORNEA GUTTATA, AND CORECTOPIA
608491
CYCLIN D-BINDING MYB-LIKE TRANSCRIPTION FACTOR 1; DMTF1
608492
OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY F, MEMBER 1; OR5F1
608493
OLFACTORY RECEPTOR, FAMILY 10, SUBFAMILY A, MEMBER 1; OR10A1
608494
OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY D, MEMBER 2; OR2D2
608495
OLFACTORY RECEPTOR, FAMILY 6, SUBFAMILY A, MEMBER 1; OR6A1
608496
OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY I, MEMBER 1; OR5I1
608497
OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY F, MEMBER 1; OR2F1
608498
ZONA PELLUCIDA-BINDING PROTEIN; ZPBP
608499
ZONA PELLUCIDA BINDING PROTEIN 2
Changed Entries:
118494
CHOLINERGIC RECEPTOR, MUSCARINIC, 3; CHRM3
118495
CHOLINERGIC RECEPTOR, MUSCARINIC, 4; CHRM4
118510
CHOLINERGIC RECEPTOR, MUSCARINIC, 1; CHRM1
138249
GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 1; GRIN1
155720
MELANOMA, UVEAL
164230
OBSESSIVE-COMPULSIVE DISORDER 1; OCD1
168000
PARAGANGLIOMAS, FAMILIAL NONCHROMAFFIN, 1; PGL1
181500
SCHIZOPHRENIA; SCZD
182135
5-@HYDROXYTRYPTAMINE RECEPTOR 2A; HTR2A
182138
SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, SEROTONIN),
219700
CYSTIC FIBROSIS; CF
600880
BUDD-CHIARI SYNDROME
601682
GLAUCOMA 1, OPEN ANGLE, C; GLC1C
602690
SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT D, INTEGRAL MEMBRANE PROTEIN;
608484
CONGENITAL CORNEAL OPACITIES, CORNEA GUTTATA, AND CORECTOPIA
February 26, 2004
New Entries:
300480
TAK1-BINDING PROTEIN 3
608486
METASTASIS SUPPRESSOR 1; MTSS1
608487
TRIPARTITE MOTIF-CONTAINING PROTEIN 5; TRIM5
608488
SPARC-RELATED MODULAR CALCIUM-BINDING 1; SMOC1
608489
STROMALIN 3; STAG3
608490
SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 1; SLC38A1
Changed Entries:
132880
NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 6; NR2F6
134797
FIBRILLIN 1; FBN1
150330
LAMIN A/C; LMNA
273300
TESTICULAR TUMORS
311770
PHOSPHATIDYLINOSITOL GLYCAN, CLASS A; PIGA
312600
RETINITIS PIGMENTOSA 2; RP2
590050
TRANSFER RNA, MITOCHONDRIAL, LEUCINE, 1; MTTL1
601398
VASCULAR ENDOTHELIAL GROWTH FACTOR B; VEGFB
601769
VITAMIN D RECEPTOR; VDR
601784
CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 1; ACCN1
601833
ALLOGRAFT INFLAMMATORY FACTOR 1; AIF1
604668
ZINC FINGER PROTEIN 264; ZNF264
606158
BSCL2 GENE; BSCL2
606191
FORMIN-BINDING PROTEIN 1; FNBP1
606524
FORMIN-BINDING PROTEIN 2; FNBP2
607444
SBDS GENE; SBDS
608486
METASTASIS SUPPRESSOR 1; MTSS1
608487
TRIPARTITE MOTIF-CONTAINING PROTEIN 5; TRIM5
608488
SPARC-RELATED MODULAR CALCIUM-BINDING 1; SMOC1
February 25, 2004
New Entries:
606691
CARCINOEMBRYONIC ANTIGEN-LIKE 1; CEAL1
608483
FUSED TOES, MOUSE, HOMOLOG OF; FTS
608485
TRANSLOCATION-ASSOCIATED MEMBRANE PROTEIN 2; TRAM2
Changed Entries:
100500
ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER
100678
ACETYL-CoA ACETYLTRANSFERASE 2; ACAT2
102642
STEROL O-ACYLTRANSFERASE 1; SOAT1
108740
ATPase, Ca(2+)-TRANSPORTING, SLOW-TWITCH; ATP2A2
182960
SPINAL MUSCULAR ATROPHY, DISTAL
200150
CHOREOACANTHOCYTOSIS; CHAC
218030
CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY
269700
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY; BSCL
270685
SPASTIC PARAPLEGIA 17; SPG17
600354
SURVIVAL OF MOTOR NEURON 1, TELOMERIC; SMN1
600726
INDIAN HEDGEHOG; IHH
600794
SPINAL MUSCULAR ATROPHY, DISTAL, TYPE V; DSMAV
600862
HIV-1 REV-BINDING PROTEIN; HRB
601311
STEROL O-ACYLTRANSFERASE 2; SOAT2
605190
TRANSLOCATION-ASSOCIATING MEMBRANE PROTEIN 1; TRAM1
605645
RESISTIN-LIKE PROTEIN, BETA; RETNLB
605978
VACUOLAR PROTEIN SORTING 13A; VPS13A
606158
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY GENE 2; BSCL2
606438
HUNTINGTON DISEASE-LIKE 2; HDL2
February 24, 2004
New Entries:
607100
NEPHROCYSTIN; NPHP1
Clinical Synopsis for
300471
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES
Changed Entries:
107670
APOLIPOPROTEIN A-II; APOA2
109535
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 5; TNFRSF5
140100
HAPTOGLOBIN; HP
143890
HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT
164160
LEPTIN; LEP
185640
RIBOSOMAL PROTEIN L7a; RPL7A
205100
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2
256100
NEPHRONOPHTHISIS 1; NPHP1
300071
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2; CSNB2
300085
CONE-ROD DYSTROPHY, X-LINKED, 2; CORDX2
300110
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1F SUBUNIT; CACNA1F
300471
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES
602109
MATRILIN 3; MATN3
603197
NEUROPATHY TARGET ESTERASE
603272
CONNECTOR ENHANCER OF KSR, DROSOPHILA, HOMOLOG OF
603896
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM
603945
EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 5; EIF2B5
605552
ABDOMINAL OBESITY-METABOLIC SYNDROME
605572
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2
606324
PARKINSON DISEASE, TYPE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7
606352
ALSIN
606598
GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1; GDAP1
Clinical Synopsis for
300200
ADRENAL HYPOPLASIA, CONGENITAL; AHC
Clinical Synopsis for
300471
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES
February 23, 2004
New Entries:
300473
NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 1; NR0B1
Changed Entries:
107910
CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1; CYP19A1
108740
ATPase, Ca(2+)-TRANSPORTING, SLOW-TWITCH; ATP2A2
118485
CYTOCHROME P450, SUBFAMILY XIA; CYP11A
146110
HYPOGONADOTROPIC HYPOGONADISM
150330
LAMIN A/C; LMNA
164730
V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1; AKT1
184757
NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 1; NR5A1
188830
PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, ALPHA; PRKAR1A
201910
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
202110
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY
300018
DOSAGE-SENSITIVE SEX REVERSAL; DSS
300097
MELANOMA ANTIGEN, FAMILY B, 1; MAGEB1
300200
ADRENAL HYPOPLASIA, CONGENITAL; AHC
300290
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA
300473
NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 1; NR0B1
305900
GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD
306190
GONADOTROPIN DEFICIENCY; GTD
308800
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS CUM OPHIASI; KFSD
313020
SPERMIDINE/SPERMINE N(1)-ACETYLTRANSFERASE; SAT
313430
SRY-BOX 3; SOX3
600617
STEROIDOGENIC ACUTE REGULATORY PROTEIN; STAR
602537
CALPAIN 5; CAPN5
603490
WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 4; WNT4
604630
NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2; NR0B2
605817
RECEPTOR-INTERACTING SERINE/THREONINE KINASE 3; RIPK3
606043
ZINC FINGER PROTEIN 331; ZNF331
607102
WILMS TUMOR 1 GENE; WT1
608160
SRY-BOX 9; SOX9
608441
SYNAPTIC NUCLEAR ENVELOPE PROTEIN 1; SYNE1
February 20, 2004
New Entries:
300474
GLYCEROL KINASE; GK
608479
SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 7; SLC26A7
608480
SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 8; SLC26A8
608481
SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 9; SLC26A9
608482
MATRIX METALLOPROTEINASE 25; MMP25
Changed Entries:
103050
ADENYLOSUCCINASE DEFICIENCY
112500
BRACHYDACTYLY, TYPE A1; BDA1
131240
ENDOTHELIN 1; EDN1
138850
GONADOTROPIN-RELEASING HORMONE RECEPTOR; GNRHR
139320
GNAS COMPLEX LOCUS; GNAS
159555
MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA; MLL
182230
SEPTOOPTIC DYSPLASIA
187050
TEETH PRESENT AT BIRTH
300290
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA
300474
GLYCEROL KINASE; GK
306190
GONADOTROPIN DEFICIENCY; GTD
307030
HYPERGLYCEROLEMIA
601464
LYMPHOID NUCLEAR PROTEIN RELATED TO AF4; LAF4
601609
L-3-@HYDROXYACYL-CoA DEHYDROGENASE, SHORT CHAIN; HADHSC
601802
HOMEO BOX GENE EXPRESSED IN ES CELLS; HESX1
603423
PR DOMAIN-CONTAINING PROTEIN 1; PRDM1
603959
CLAUDIN 16; CLDN16
604980
GTPase-ACTIVATING PROTEIN, RAC, 1; RACGAP1
608232
LEUKEMIA, CHRONIC MYELOID; CML
608382
DNAJ, E. COLI, HOMOLOG OF, SUBFAMILY A, MEMBER 3; DNAJA3
February 20, 2004
New Entries:
608477
ALDO-KETO REDUCTASE FAMILY 7, MEMBER A3; AKR7A3
608478
ALDO-KETO REDUCTASE FAMILY 7, MEMBER A4
Changed Entries:
603215
N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEIN, ALPHA; NAPA
603418
ALDO-KETO REDUCTASE FAMILY 7, MEMBER A2; AKR7A2
608467
STONIN 2
608472
BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE II
608478
ALDO-KETO REDUCTASE FAMILY 7, MEMBER A4
February 19, 2004
New Entries:
606889
ALZHEIMER DISEASE, FAMILIAL, TYPE 4; AD4
608472
BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE II
608474
MYOPIA 5
608475
3-@HYDROXYISOBUTYRATE DEHYDROGENASE; HIBADH
608476
TBK1-BINDING PROTEIN 1
Changed Entries:
100800
ACHONDROPLASIA; ACH
104300
ALZHEIMER DISEASE; AD
109675
SIALYLTRANSFERASE 1; SIAT1
113900
PROGRESSIVE FAMILIAL HEART BLOCK, TYPE I; PFHBI
118450
ALAGILLE SYNDROME; AGS
120200
COLOBOMA, OCULAR
125660
DESMIN; DES
130160
ELASTIN; ELN
144250
HYPERLIPIDEMIA, FAMILIAL COMBINED; FCHL
160700
MYOPIA 2; MYP2
163950
NOONAN SYNDROME 1; NS1
176801
PROSAPOSIN; PSAP
177850
PSEUDOXANTHOMA ELASTICUM, AUTOSOMAL DOMINANT; PXE
182381
SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 2;
187950
THROMBOCYTHEMIA, ESSENTIAL
188360
THYMOCYTE ANTIGEN CD1B; CD1B
191100
TUBEROUS SCLEROSIS; TS
207750
APOLIPOPROTEIN C-II DEFICIENCY
212750
CELIAC DISEASE; CD
218030
CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY
219700
CYSTIC FIBROSIS; CF
222300
WOLFRAM SYNDROME
232300
GLYCOGEN STORAGE DISEASE II
245000
PAPILLON-LEFEVRE SYNDROME; PALS
248600
MAPLE SYRUP URINE DISEASE
254210
MYASTHENIA GRAVIS, FAMILIAL INFANTILE; FIMG
263200
POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD
264800
PSEUDOXANTHOMA ELASTICUM, AUTOSOMAL RECESSIVE; PXE
277300
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE, 1
300352
CREATINE DEFICIENCY SYNDROME, X-LINKED
302380
CATEL-MANZKE SYNDROME
304700
MOHR-TRANEBJAERG SYNDROME; MTS
600047
ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 2; ABCA2
600510
GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1
600759
PRESENILIN 2; PSEN2
601057
PROGRAMMED CELL DEATH 6; PDCD6
601144
BRUGADA SYNDROME
601329
LIM DOMAIN KINASE 1; LIMK1
601679
GENERAL TRANSCRIPTION FACTOR II-I; GTF2I
602291
FORKHEAD BOX J1; FOXJ1
602421
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
603072
AURORA KINASE A; AURKA
604970
AURORA KINASE B; AURKB
605918
SPONDIN 2; SPON2
606003
TRANSALDOLASE DEFICIENCY
606889
ALZHEIMER DISEASE, FAMILIAL, TYPE 4; AD4
607093
5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR
608464
VG5Q GENE
608472
BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE II
February 18, 2004
New Entries:
608470
CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1
608471
CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A
608473
ANAPHASE-PROMOTING COMPLEX, SUBUNIT 1; ANAPC1
Changed Entries:
104311
PRESENILIN 1; PSEN1
107670
APOLIPOPROTEIN A-II; APOA2
107730
APOLIPOPROTEIN B; APOB
120360
MATRIX METALLOPROTEINASE 2; MMP2
121800
CORNEAL DYSTROPHY, CRYSTALLINE, OF SCHNYDER
121820
CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE
121900
GROENOUW TYPE I CORNEAL DYSTROPHY; CDGG1
122200
CORNEAL DYSTROPHY, LATTICE TYPE I; CDL1
123900
VILLIN 2; VIL2
133170
ERYTHROPOIETIN; EPO
138190
SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER
146930
INTERLEUKIN 8; IL8
151385
RUNT-RELATED TRANSCRIPTION FACTOR 1; RUNX1
159440
MYELIN PROTEIN ZERO; MPZ
162200
NEUROFIBROMATOSIS, TYPE I; NF1
174763
POLYMERASE, DNA, GAMMA; POLG
176807
PROSTATE CANCER
176960
PROTEIN KINASE C, ALPHA; PRKCA
177000
PROTOPORPHYRIA, ERYTHROPOIETIC
177061
MYRISTOYLATED ALANINE-RICH PROTEIN KINASE C SUBSTRATE; MARCKS
181350
EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT; EDMD2
190196
TRANSGLUTAMINASE 2; TGM2
191160
TUMOR NECROSIS FACTOR; TNF
204870
CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE
219000
FRASER SYNDROME
252800
ALPHA-L-IDURONIDASE; IDUA
260565
PEHO SYNDROME
300389
RETINITIS PIGMENTOSA 3; RP3
300392
WAS GENE; WAS
301000
WISKOTT-ALDRICH SYNDROME; WAS
309470
MENTAL RETARDATION, X-LINKED, SYNDROMIC 3; MRXS3
312610
RETINITIS PIGMENTOSA GTPase REGULATOR; RPGR
314670
X INACTIVATION-SPECIFIC TRANSCRIPT; XIST
600163
SODIUM CHANNEL, VOLTAGE-GATED, TYPE V, ALPHA SUBUNIT; SCN5A
600262
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2; PTGS2
600409
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD
601395
CHEMOKINE, CC MOTIF, LIGAND 3-LIKE PROTEIN 1; CCL3L1
601536
NAVAJO BRAIN STEM SYNDROME
601553
HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD
601692
TRANSFORMING GROWTH FACTOR, BETA-INDUCED, 68-KD; TGFBI
602082
CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II; CDB2
602544
PARKIN; PARK2
603461
CELL DIVISION CYCLE 16, S. CEREVISIAE, HOMOLOG OF; CDC16
603462
CELL DIVISION CYCLE 23; CDC23
603830
LONG QT SYNDROME 3; LQT3
603937
RETINITIS PIGMENTOSA 1 GENE; RP1
604400
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5
604597
GLUTAMATE RECEPTOR-INTERACTING PROTEIN 1; GRIP1
605082
RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1; RASSF1
605257
ACTIVATION-INDUCED CYTIDINE DEAMINASE; AICDA
606692
RING FINGER- AND WD REPEAT DOMAIN-CONTAINING PROTEIN 1; RFWD1
606838
APOPTOSIS-ASSOCIATED SPECK-LIKE PROTEIN CONTAINING A CARD
606946
ANAPHASE-PROMOTING COMPLEX, SUBUNIT 2; ANAPC2
606947
ANAPHASE-PROMOTING COMPLEX, SUBUNIT 4; ANAPC4
606949
ANAPHASE-PROMOTING COMPLEX, SUBUNIT 7; ANAPC7
607541
CORNEAL DYSTROPHY, AVELLINO TYPE; CDA
607572
LEPROSY, SUSCEPTIBILITY TO, 2
607677
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I
607822
ALZHEIMER DISEASE, FAMILIAL, TYPE 3; AD3
608337
OTU DOMAIN-CONTAINING UBIQUITIN ALDEHYDE-BINDING PROTEIN 1
608427
PARKIN COREGULATED GENE; PACRG
608470
CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1
February 18, 2004
New Entries:
608466
ACTIVATOR OF HEAT-SHOCK 90-KD PROTEIN ATPase 1; AHSA1
608467
STONIN 2
608468
CARBON CATABOLITE REPRESSION 4, S. CEREVISIAE, HOMOLOG OF; CCRN4L
608469
DEAD/H BOX 17; DDX17
Clinical Synopsis for
608390
MYOTONIA, POTASSIUM-AGGRAVATED
Changed Entries:
102582
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; STAT3
103220
SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 4; SLC25A4
105800
ANEURYSM, INTRACRANIAL BERRY
109535
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 5; TNFRSF5
114107
PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP3CC
118470
CHOLESTERYL ESTER TRANSFER PROTEIN, PLASMA; CETP
118504
CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4; CHRNA4
120920
MEMBRANE COFACTOR PROTEIN; MCP
123900
VILLIN 2; VIL2
124015
CYTOCHROME P450 REDUCTASE; POR
136430
FOLATE RECEPTOR 1, ADULT; FOLR1
143100
HUNTINGTON DISEASE; HD
147670
INSULIN RECEPTOR; INSR
150330
LAMIN A/C; LMNA
150370
LAMININ RECEPTOR 1; LAMR1
153622
MACROPHAGE SCAVENGER RECEPTOR; MSR1
154040
RD RNA-BINDING PROTEIN; RDBP
158590
MUSCULAR ATROPHY, ADULT SPINAL
164011
NUCLEAR FACTOR KAPPA-B, SUBUNIT 1; NFKB1
167414
PAIRED BOX GENE 5; PAX5
167416
PAIRED BOX GENE 9; PAX9
168350
MOVED TO 168300
168600
PARKINSON DISEASE; PD
175700
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS
176670
HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
176943
FIBROBLAST GROWTH FACTOR RECEPTOR 2; FGFR2
177020
PROTEINASE 3; PRTN3
178500
PULMONARY FIBROSIS, IDIOPATHIC
182960
SPINAL MUSCULAR ATROPHY, DISTAL
207410
ANTLEY-BIXLER SYNDROME; ABS
227646
FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
235400
HEMOLYTIC-UREMIC SYNDROME; HUS
236200
HOMOCYSTINURIA
246900
DIHYDROLIPOAMIDE DEHYDROGENASE; DLD
248370
MANDIBULOACRAL DYSPLASIA; MAD
248610
DIHYDROLIPOAMIDE BRANCHED-CHAIN TRANSACYLASE; DBT
248611
BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, BETA POLYPEPTIDE; BCKDHB
259500
OSTEOGENIC SARCOMA
268210
RHABDOMYOSARCOMA 1; RMS1
300150
SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER A5; SLC25A5
300307
T-BOX 22; TBX22
303400
CLEFT PALATE, X-LINKED; CPX
600264
ARGININE VASOPRESSIN RECEPTOR 1B; AVPR1B
600502
IMMUNOGLOBULIN MU BINDING PROTEIN 2; IGHMBP2
600513
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1
600794
SPINAL MUSCULAR ATROPHY, DISTAL, TYPE V; DSMAV
600859
JTV1 GENE
601205
SINE OCULIS HOMEO BOX, DROSOPHILA, HOMOLOG OF, 1; SIX1
601284
ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 1; ACVRL1
601487
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG
601637
CYTOCHROME P450, FAMILY 51, SUBFAMILY A, POLYPEPTIDE 1; CYP51A1
602291
FORKHEAD, DROSOPHILA, HOMOLOG-LIKE 13; FKHL13
602544
PARKIN; PARK2
602783
SPASTIC PARAPLEGIA 7 GENE; SPG7
603013
SCHIZOPHRENIA 6; SCZD6
603215
N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEIN, ALPHA; NAPA
603700
ARACHIDONATE 5-LIPOXYGENASE-ACTIVATING PROTEIN; ALOX5AP
604277
SPG4 GENE; SPG4
604320
SPINAL MUSCULAR ATROPHY WITH RESPIRATORY DISTRESS 1; SMARD1
605357
STONED B/TFIIA-ALPHA/BETA-LIKE FACTOR
606002
SPINOCEREBELLAR ATAXIA, RECESSIVE, NON-FRIEDREICH TYPE 1
606410
ANTHRAX TOXIN RECEPTOR 1; ANTXR1
606679
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 5;
606761
MALONYL-CoA DECARBOXYLASE; MLYCD
606843
IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3
607991
SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER 3; SLC8A3
608465
SENATAXIN
Clinical Synopsis for
160500
MYOPATHY, DISTAL 1; MPD1
Clinical Synopsis for
168300
PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC
Clinical Synopsis for
168350
MOVED TO 168300
Clinical Synopsis for
170400
HYPOKALEMIC PERIODIC PARALYSIS; HOKPP
Clinical Synopsis for
170500
HYPERKALEMIC PERIODIC PARALYSIS; HYPP
Clinical Synopsis for
246900
DIHYDROLIPOAMIDE DEHYDROGENASE; DLD
Clinical Synopsis for
248610
DIHYDROLIPOAMIDE BRANCHED-CHAIN TRANSACYLASE; DBT
Clinical Synopsis for
248611
BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, BETA POLYPEPTIDE; BCKDHB
February 13, 2004
New Entries:
606504
MLN51 GENE
606692
RING FINGER- AND WD REPEAT DOMAIN-CONTAINING PROTEIN 1; RFWD1
608464
VG5Q GENE
608465
SENATAXIN
Changed Entries:
123900
VILLIN 2; VIL2
125220
DEFENSIN, ALPHA, 1; DEFA1
139320
GNAS COMPLEX LOCUS; GNAS
149000
KLIPPEL-TRENAUNAY-WEBER SYNDROME
179410
RADIXIN; RDX
191390
ULCERATIVE COLITIS, SUSCEPTIBILITY TO
228600
FIBROMATOSIS, JUVENILE HYALINE
236490
HYALINOSIS, INFANTILE SYSTEMIC
268800
SANDHOFF DISEASE
309845
MOESIN; MSN
600246
ELK4, ETS-DOMAIN PROTEIN; ELK4
600354
SURVIVAL OF MOTOR NEURON 1, TELOMERIC; SMN1
600702
SODIUM CHANNEL, VOLTAGE-GATED, TYPE VIII, ALPHA SUBUNIT; SCN8A
600716
PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8; PTPN8
601373
CHEMOKINE, CC MOTIF, RECEPTOR 5; CCR5
601693
UNCOUPLING PROTEIN 2; UCP2
601739
MEIS1, MOUSE, HOMOLOG OF, 1; MEIS1
602695
TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 12; TNFSF12
604378
BECLIN 1; BECN1
604522
DEFENSIN, ALPHA, 3; DEFA3
604933
MutY, E. COLI, HOMOLOG OF; MUTYH
604986
BRCA1-ASSOCIATED PROTEIN; BRAP
606002
SPINOCEREBELLAR ATAXIA, RECESSIVE, NON-FRIEDREICH TYPE 1
606692
RING FINGER- AND WD REPEAT DOMAIN-CONTAINING PROTEIN 1; RFWD1
608041
ANTHRAX TOXIN RECEPTOR 2; ANTXR2
608465
SENATAXIN
Clinical Synopsis for
149000
KLIPPEL-TRENAUNAY-WEBER SYNDROME
February 12, 2004
New Entries:
607234
MAS-RELATED GENE MRGG
608463
APOPTOSIS-ANTAGONIZING TRANSCRIPTION FACTOR; AATF
Changed Entries:
120970
CONE-ROD DYSTROPHY 2; CORD2
123590
CRYSTALLIN, ALPHA-B; CRYAB
157660
MITOCHONDRIAL RNA-PROCESSING ENDORIBONUCLEASE, RNA COMPONENT OF; RMRP
171060
ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 4; ABCB4
188400
DIGEORGE SYNDROME; DGS
192340
ARGININE VASOPRESSIN; AVP
192430
VELOCARDIOFACIAL SYNDROME
193300
VON HIPPEL-LINDAU SYNDROME; VHL
201910
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
208050
ARTERIAL TORTUOSITY
217095
CONOTRUNCAL HEART MALFORMATIONS; CTHM
219080
CUSHING DISEASE, ADRENAL
600156
HIRSCHSPRUNG DISEASE MODIFIER 1
600803
CHOLELITHIASIS
601081
ATP-BINDING CASSETTE, SUBFAMILY 3, MEMBER 2; ABCD2
601419
DESMIN-RELATED MYOPATHY
601530
SEQUESTOSOME 1; SQSTM1
601556
ATAXIN 1; ATX1
601816
BILIRUBIN, ELEVATED CONCENTRATIONS OF, IN SERUM
601914
PROLINE ARGININE-RICH END LEUCINE-RICH REPEAT PROTEIN; PRELP
602054
T-BOX 1; TBX1
603150
ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, DELTA SUBUNIT;
604392
ARYLHYDROCARBON-INTERACTING RECEPTOR PROTEIN-LIKE 1; AIPL1
607042
CLN3 GENE; CLN3
607379
NEUROFIBROMIN 2; NF2
607981
NEDD8 ULTIMATE BUSTER 1
608441
SYNAPTIC NUCLEAR ENVELOPE PROTEIN 1; SYNE1
February 11, 2004
New Entries:
300477
FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER A; FAM9A
300478
FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER B; FAM9B
300479
FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER C; FAM9C
608461
COLLAGEN, TYPE XXVII, ALPHA-1; COL27A1
608462
HIRSCHSPRUNG DISEASE MODIFIER 2
Changed Entries:
104300
ALZHEIMER DISEASE; AD
108500
EPISODIC ATAXIA, TYPE 2; EA2
126375
DNA METHYLTRANSFERASE 1; DNMT1
126453
DOPAMINE RECEPTOR D5; DRD5
142623
HIRSCHSPRUNG DISEASE
143000
HORNER SYNDROME, CONGENITAL
147720
INTERLEUKIN 1-BETA; IL1B
163905
HIGH MOBILITY GROUP BOX 1; HMGB1
185250
MATRIX METALLOPROTEINASE 3; MMP3
185620
SURFEIT 1; SURF1
201910
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
202110
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY
245200
KRABBE DISEASE
256000
LEIGH SYNDROME; LS
272120
SUDDEN INFANT DEATH SYNDROME
590060
TRANSFER RNA, MITOCHONDRIAL, LYSINE; MTTK
600214
ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGER
600409
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD
601995
TENASCIN-R; TNR
603099
1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 1; AGPAT1
604759
SYNAPTONEMAL COMPLEX PROTEIN 3; SYCP3
605996
DOM3, C. ELEGANS, HOMOLOG OF, Z; DOM3Z
606798
BLEPHAROSPASM, BENIGN ESSENTIAL
606875
HIRSCHSPRUNG DISEASE, SHORT-SEGMENT, 3
607136
SPINOCEREBELLAR ATAXIA 17; SCA17
607139
FANCONI ANEMIA COMPLEMENTATION GROUP A GENE; FANCA
February 10, 2004
New Entries:
608423
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1F; LGMD1F
608456
COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE
608457
CHROMOBOX HOMOLOG 7; CBX7
608458
NEUROCHONDRIN
608459
CYCLIN-DEPENDENT KINASE-LIKE 3; CDKL3
608460
ZINC FINGER PROTEIN 276; ZFP276
Changed Entries:
106180
ANGIOTENSIN I-CONVERTING ENZYME; ACE
120620
COMPLEMENT COMPONENT RECEPTOR 1; CR1
123810
cAMP RESPONSE ELEMENT-BINDING PROTEIN 1; CREB1
142410
TRANSCRIPTION FACTOR 1; TCF1
144650
HYPERLIPOPROTEINEMIA, TYPE V
166200
OSTEOGENESIS IMPERFECTA, TYPE I
166220
OSTEOGENESIS IMPERFECTA, TYPE IV
176980
PROTEIN KINASE C, GAMMA; PRKCG
180069
RETINAL PIGMENT EPITHELIUM-SPECIFIC PROTEIN, 65-KD; RPE65
189965
CCAAT/ENHANCER-BINDING PROTEIN, BETA; CEBPB
190196
TRANSGLUTAMINASE 2; TGM2
191830
UROGENITAL ADYSPLASIA, HEREDITARY
194350
WT LIMB-BLOOD SYNDROME
207800
ARGININEMIA
210000
BEHR SYNDROME
259420
OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE
300259
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO INFECTION BY
300292
FORKHEAD BOX P3; FOXP3
304790
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED;
309550
FRAGILE SITE MENTAL RETARDATION 1 GENE; FMR1
600234
3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2, MITOCHONDRIAL; HMGCS2
601545
PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, ALPHA SUBUNIT;
601754
UBIQUITIN FUSION DEGRADATION 1-LIKE; UFD1L
602404
PARKINSON DISEASE 3, AUTOSOMAL DOMINANT LEWY BODY; PARK3
603501
POLY(ADP-RIBOSE) GLYCOHYDROLASE; PARG
604834
TANK-BINDING KINASE 1; TBK1
604933
MutY, E. COLI, HOMOLOG OF; MUTYH
605189
DICKKOPF, XENOPUS, HOMOLOG OF, 1; DKK1
605361
SPINOCEREBELLAR ATAXIA 14; SCA14
606232
CHROMOSOME 22q13.3 DELETION SYNDROME
606896
DYSLEXIA, SPECIFIC, 5; DYX5
607432
LISSENCEPHALY I; LIS1
607949
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO INFECTION BY, 1
608451
ETHE1 GENE; ETHE1
608456
COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE
Clinical Synopsis for
119530
OROFACIAL CLEFT 1; OFC1
February 9, 2004
New Entries:
608451
ETHYLMALONIC ENCEPHALOPATHY GENE 1; ETHE1
608453
CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE C; CBLC
608454
KNOBLOCH SYNDROME, TYPE II
Changed Entries:
106180
ANGIOTENSIN I-CONVERTING ENZYME; ACE
120328
COLLAGEN, TYPE XVIII, ALPHA-1; COL18A1
123970
CYTOCHROME C
126453
DOPAMINE RECEPTOR D5; DRD5
143465
ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD
147265
INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 1; ITPR1
151443
LEUKEMIA INHIBITORY FACTOR RECEPTOR; LIFR
165360
CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE HOMOLOG;
176805
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1; PTGS1
201910
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
209950
ATYPICAL MYCOBACTERIOSIS, FAMILIAL
212065
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia
222100
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM
224500
DYSTONIA MUSCULORUM DEFORMANS 2; DYT2
250100
METACHROMATIC LEUKODYSTROPHY
254780
MYOCLONIC EPILEPSY OF LAFORA
259420
OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE
267750
KNOBLOCH SYNDROME; KNO
300335
ANGIOTENSIN I-CONVERTING ENZYME 2; ACE2
302800
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED, 1; CMTX1
600262
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2; PTGS2
600985
TENASCIN-XB; TNXB
601253
CAVEOLIN 3; CAV3
601559
STUVE-WIEDEMANN SYNDROME
601773
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N; PTPRN
602006
MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 2; MAPKAPK2
602473
ENCEPHALOPATHY, ETHYLMALONIC
604491
CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE B; CBLB
604710
LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 4; LTBP4
604759
SYNAPTONEMAL COMPLEX PROTEIN 3; SYCP3
605312
BONE MORPHOGENETIC PROTEIN, PLACENTAL
607585
ATAXIA-TELANGIECTASIA MUTATED GENE; ATM
608118
ZINC IN BREAST MILK, REDUCED
608452
PLATELET-DERIVED GROWTH FACTOR C; PDGFC
Clinical Synopsis for
184260
SPONDYLOMETAPHYSEAL DYSPLASIA WITH DENTINOGENESIS IMPERFECTA
Clinical Synopsis for
234250
HALL-RIGGS MENTAL RETARDATION SYNDROME
Clinical Synopsis for
603546
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS
February 6, 2004
New Entries:
608443
MENTAL RETARDATION, NONSYNDROMIC, AUTOSOMAL RECESSIVE, 3
608452
PLATELET-DERIVED GROWTH FACTOR C; PDGFC
Clinical Synopsis for
602557
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE
Clinical Synopsis for
603005
3-PRIME-@PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 2; PAPSS2
Clinical Synopsis for
603546
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS
Changed Entries:
101000
NEUROFIBROMATOSIS, TYPE II; NF2
113705
BREAST CANCER 1 GENE; BRCA1
119530
OROFACIAL CLEFT 1; OFC1
120960
COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II
124080
CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2
125660
DESMIN; DES
139340
GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE
142983
MUSCLE SEGMENT HOMEO BOX, DROSOPHILA, HOMOLOG OF, 1; MSX1
164761
REARRANGED DURING TRANSFECTION PROTOONCOGENE; RET
170998
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA
176000
PORPHYRIA, ACUTE INTERMITTENT
176807
PROSTATE CANCER
185300
STURGE-WEBER SYNDROME
249500
MENTAL RETARDATION, NONSYNDROMIC, AUTOSOMAL RECESSIVE
256550
NEURAMINIDASE DEFICIENCY
258480
OPSISMODYSPLASIA
261000
PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR
276000
PROTEASE, SERINE, 1; PRSS1
600131
EPILEPSY, CHILDHOOD ABSENCE, 1; ECA1
600185
BREAST CANCER 2 GENE; BRCA2
600276
NOTCH, DROSOPHILA, HOMOLOG OF, 3; NOTCH3
600409
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD
600669
EPILEPSY, IDIOPATHIC GENERALIZED; IGE
601487
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG
601530
SEQUESTOSOME 1; SQSTM1
601564
PROTEASE, SERINE, 2; PRSS2
602006
MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 2; MAPKAPK2
602109
MATRILIN 3; MATN3
603005
3-PRIME-@PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 2; PAPSS2
603363
CGG-BINDING PROTEIN 1; CGGBP1
603546
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS
604134
A DISINTEGRIN-LIKE AND METALLOPROTEASE WITH THROMBOSPONDIN TYPE 1
604840
FK506-BINDING PROTEIN 8; FKBP8
605078
TAR DNA-BINDING PROTEIN; TARDBP
605238
HISTAMINE N-METHYLTRANSFERASE; HNMT
605833
BONE MINERAL DENSITY VARIATION 2
606157
PANTOTHENATE KINASE 2; PANK2
606397
USH3A GENE; USH3A
606530
CYTOCHROME P450, SUBFAMILY XXVIIA, POLYPEPTIDE 1; CYP27A1
606800
GLUCOSIDASE, ALPHA, ACID; GAA
606904
EPILEPSY, JUVENILE MYOCLONIC; JME
607102
WILMS TUMOR 1 GENE; WT1
607236
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,
607566
EPM2A GENE; EPM2A
607631
EPILEPSY, JUVENILE ABSENCE; JAE
608272
NEURAMINIDASE 1; NEU1
Clinical Synopsis for
108500
EPISODIC ATAXIA, TYPE 2; EA2
Clinical Synopsis for
183849
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS
Clinical Synopsis for
184260
SPONDYLOMETAPHYSEAL DYSPLASIA WITH DENTINOGENESIS IMPERFECTA
Clinical Synopsis for
603005
3-PRIME-@PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 2; PAPSS2
February 5, 2004
New Entries:
300476
CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3
608444
MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA 5; MLL5
608445
SPEECH-SOUND DISORDER
608446
MYOCARDIAL INFARCTION, PREMATURE, SUSCEPTIBILITY TO
608447
CAROTID INTIMAL MEDIAL THICKNESS
608448
INFLAMMATORY BOWEL DISEASE 9; IBD9
608449
POLYPYRIMIDINE TRACT-BINDING PROTEIN 2; PTBP2
608450
B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA-EXPRESSED GENE; BLACE
Changed Entries:
104300
ALZHEIMER DISEASE; AD
113505
BRAIN-DERIVED NEUROTROPHIC FACTOR; BDNF
114090
CALPASTATIN; CAST
119580
BLEPHAROCHEILODONTIC SYNDROME
124080
CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2
125220
DEFENSIN, ALPHA, 1; DEFA1
134660
GLUTATHIONE S-TRANSFERASE, PI; GSTP1
136425
FOLATE RECEPTOR 2, FETAL; FOLR2
138350
GLUTATHIONE S-TRANSFERASE, MU-1; GSTM1
173900
POLYCYSTIC KIDNEYS
173910
POLYCYSTIC KIDNEY DISEASE 2; PKD2
186790
CD3 ANTIGEN, DELTA SUBUNIT; CD3D
193300
VON HIPPEL-LINDAU SYNDROME; VHL
267300
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS
300029
RETINITIS PIGMENTOSA 15; RP15
300071
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2; CSNB2
300085
CONE-ROD DYSTROPHY, X-LINKED, 2; CORDX2
300095
SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER
300476
CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3
304020
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1
310200
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD
516060
ATP SYNTHASE 6; MTATP6
600666
POLYCYSTIC KIDNEY DISEASE 3, AUTOSOMAL DOMINANT; PKD3
600890
HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE,
601040
SCAVENGER RECEPTOR CLASS B, MEMBER 1; SCARB1
601212
PROTEIN-TYROSINE KINASE 2, BETA; PTK2B
601402
MYELOID LEUKEMIA FACTOR 1; MLF1
602096
ALZHEIMER DISEASE, FAMILIAL, TYPE 5
602548
OPIOID RECEPTOR-LIKE 1; OPRL1
602601
LOW DENSITY LIPOPROTEIN, OXIDIZED, RECEPTOR 1; OLR1
602722
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR
603590
ACETYLGLUCOSAMINYLTRANSFERASE-LIKE PROTEIN; LARGE
603684
LIPASE, ENDOTHELIAL; LIPG
604522
DEFENSIN, ALPHA, 3; DEFA3
605239
ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 4; ATP6V0A4
605286
CALPAIN 10; CAPN10
606896
DYSLEXIA, SPECIFIC, 5; DYX5
607929
CHROMOSOME 7 OPEN READING FRAME 22; C7ORF22
608271
MICROTUBULE-ACTIN CROSS-LINKING FACTOR 1; MACF1
608410
OBESITY, SUSCEPTIBILITY TO, ON CHROMOSOME 4
February 4, 2004
New Entries:
608441
SYNAPTIC NUCLEAR ENVELOPE PROTEIN 1; SYNE1
608442
SYNAPTIC NUCLEAR ENVELOPE PROTEIN 2; SYNE2
Changed Entries:
107741
APOLIPOPROTEIN E; APOE
120700
COMPLEMENT COMPONENT 3; C3
125853
DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM
133780
EXUDATIVE VITREORETINOPATHY, FAMILIAL; EVR
155240
THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC
158900
FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A; FSHMD1A
168461
CYCLIN D1; CCND1
182284
CHEMOKINE, CC MOTIF, LIGAND 4; CCL4
185300
STURGE-WEBER SYNDROME
218030
CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY
227650
FANCONI ANEMIA; FA
261600
PHENYLKETONURIA
300121
DOUBLECORTIN; DCX
300156
CANCER/TESTIS ANTIGEN 1; CTAG1
312170
PYRUVATE DEHYDROGENASE COMPLEX, E1-ALPHA POLYPEPTIDE 1; PDHA1
600890
HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE,
602192
A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 10; ADAM10
602851
MONOGENIC AUDIOGENIC SEIZURE SUSCEPTIBILITY 1, MOUSE, HOMOLOG OF;
603460
CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT 1; CDK5R1
603782
CHEMOKINE, CC MOTIF, LIGAND 4-LIKE; CCL4L
603969
TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13B; TNFSF13B
604087
CYTOCHROME P450, FAMILY 46, SUBFAMILY A, POLYPEPTIDE 1; CYP46A1
605427
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 4;
605441
ADIPOSE MOST ABUNDANT GENE TRANSCRIPT 1
605472
USHER SYNDROME, TYPE IIC; USH2C
605646
SOLUTE CARRIER FAMILY 26, MEMBER 4; SLC26A4
605820
NONAKA MYOPATHY; NM
607278
OSTEOFIBROUS DYSPLASIA
February 3, 2004
New Entries:
300471
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES
300472
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,
300475
CONTIGUOUS ABCD1/DXS1375E DELETION SYNDROME
608406
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND
608440
LACTAMASE, BETA; LACTB
Clinical Synopsis for
608432
CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM
Changed Entries:
111680
RHESUS BLOOD GROUP, D ANTIGEN; RHD
113705
BREAST CANCER 1 GENE; BRCA1
122470
CORNELIA DE LANGE SYNDROME 1; CDL1
123810
cAMP RESPONSE ELEMENT-BINDING PROTEIN 1; CREB1
125420
DENTIN DYSPLASIA, TYPE II
125485
DENTIN SIALOPHOSPHOPROTEIN; DSPP
136535
FORMIN; FMN
140300
HASHIMOTO THYROIDITIS
142669
HIP DYSPLASIA, BEUKES TYPE
143100
HUNTINGTON DISEASE; HD
165720
OSTEOARTHRITIS
170261
TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX,
191170
TUMOR PROTEIN p53; TP53
275000
GRAVES DISEASE
300104
GDP DISSOCIATION INHIBITOR 1; GDI1
300139
IMMUNOGLOBULIN-BINDING PROTEIN 1; IGBP1
300371
ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 1; ABCD1
300398
B-CELL RECEPTOR-ASSOCIATED PROTEIN 31; BCAP31
300475
CONTIGUOUS ABCD1/DXS1375E DELETION SYNDROME
306400
GRANULOMATOUS DISEASE, CHRONIC; CGD
600527
EPHRIN B2; EFNB2
600618
ETS VARIANT GENE 6; ETV6
600985
TENASCIN-XB; TNXB
601040
SCAVENGER RECEPTOR CLASS B, MEMBER 1; SCARB1
602260
PERIOD, DROSOPHILA, HOMOLOG OF; PER1
602297
EPHRIN B3; EFNB3
604517
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1; PPARGC1
605646
SOLUTE CARRIER FAMILY 26, MEMBER 4; SLC26A4
606512
PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 1; PACSIN1
607095
ANAUXETIC DYSPLASIA
607139
FANCONI ANEMIA COMPLEMENTATION GROUP A GENE; FANCA
607379
NEUROFIBROMIN 2; NF2
607697
SET-BINDING FACTOR 2; SBF2
608432
CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM
608440
LACTAMASE, BETA; LACTB
Clinical Synopsis for
208230
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD; PPAC
Clinical Synopsis for
234250
HALL-RIGGS MENTAL RETARDATION SYNDROME
Clinical Synopsis for
277950
WINCHESTER DISEASE
February 2, 2004
New Entries:
608438
TOUSLED-LIKE KINASE 1; TLK1
608439
TOUSLED-LIKE KINASE 2; TLK2
Changed Entries:
127550
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT
139396
GUANYLATE CYCLASE 1, SOLUBLE, ALPHA-3; GUCY1A3
139397
GUANYLATE CYCLASE 1, SOLUBLE, BETA-3; GUCY1B3
141900
HEMOGLOBIN--BETA LOCUS; HBB
142763
H2A HISTONE FAMILY, MEMBER Z; H2AFZ
151623
LI-FRAUMENI SYNDROME; LFS
160900
DYSTROPHIA MYOTONICA 1
176801
PROSAPOSIN; PSAP
180385
LIM DOMAIN ONLY 2; LMO2
182284
CHEMOKINE, CC MOTIF, LIGAND 4; CCL4
186790
CD3 ANTIGEN, DELTA SUBUNIT; CD3D
188370
THYMOCYTE ANTIGEN CD1A; CD1A
188410
THYMOCYTE ANTIGEN CD1D; CD1D
192132
ATPase, H+ TRANSPORTING, LYSOSOMAL, 56/58-KD, V1 SUBUNIT B, ISOFORM
208500
ASPHYXIATING THORACIC DYSTROPHY; ATD
227645
FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC
259730
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS
267300
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS
300400
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1
308380
INTERLEUKIN 2 RECEPTOR, GAMMA; IL2RG
600418
AMPHIPHYSIN; AMPH
601828
NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; NR4A2
602322
TELOMERASE RNA COMPONENT; TERC
602384
PHOSPHOLIPASE D2; PLD2
603782
CHEMOKINE, CC MOTIF, LIGAND 4-LIKE; CCL4L
603902
BETA THALASSEMIA, DOMINANT INCLUSION BODY TYPE
605377
DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK
608074
PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN; PDCD6IP
608148
SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 2; SATB2
Disclaimer
|
Write to the Help Desk
|
Privacy Policy
NCBI
|
NLM
|
NIH